Single-agent maintenance therapy for advanced non-small cell lung cancer (NSCLC): a systematic review and Bayesian network meta-analysis of 26 randomized controlled trials

BACKGROUND: The benefit of maintenance therapy has been confirmed in patients with non-progressing non-small cell lung cancer (NSCLC) after first-line therapy by many trials and meta-analyses. However, since few head-to-head trials between different regimens have been reported, clinicians still have...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qinxue, Huang, Haobin, Zeng, Xiaoning, Ma, Yuan, Zhao, Xin, Huang, Mao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2016
Materias:
Evidence Based Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075715/
https://www.ncbi.nlm.nih.gov/pubmed/27781159
http://dx.doi.org/10.7717/peerj.2550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075715/
https://www.ncbi.nlm.nih.gov/pubmed/27781159
http://dx.doi.org/10.7717/peerj.2550

Ejemplares similares